SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosebank Regulatory News (ROSE)

Share Price Information for Rosebank (ROSE)

Share Price is delayed by 15 minutes
Get Live Data
350.00    12.00 (3.55%)
Bid:
350.00
Ask:
352.00
Spread: 2.00 (0.571%)
Market Cap: £3.46b
ROSE Live PriceLast checked at - London Stock Exchange

Intraday Rosebank Share Chart

Uranium Update

12 Apr 2007 07:00

Vane Minerals PLC12 April 2007 12th April 2007 VANE Minerals Plc (AIM: VML) Uranium Assets Update £1 Million Raised By Way Of A Convertible Loan Note VANE Minerals Plc ("VANE" or "the Company") announces that, further to theprogress recently announced with the expansion of its US based portfolio ofuranium assets and the commencement of drilling at certain projects, the Boardis undertaking a strategic review of its options in order to maximiseshareholder benefit from its uranium portfolio. The Board recognises the risinginterest, particularly in the US and Canada, of institutions and other partiesin companies operating in the uranium sector. This has led to substantialvaluations and major fundraising opportunities for some asset-rich uraniumcompanies in those markets. There is no certainty as to the outcome of any such review but in the currentenvironment the Board considers that it has a duty in the best interests ofshareholders to explore what options may be available to extract optimum valuefrom its now sizeable uranium portfolio. An update on any progress will beannounced in due course. Loan note To facilitate the fast track exploration and drilling at the Company's variousNorth American uranium projects, the Company has conditionally agreed to raise£1,000,000 through the issue of a fixed-rate unsecured convertible loan note(the "Loan Note") to Geiger Counter Limited. The issue of the Loan Note is conditional upon shareholder approval which willbe sought at an Extraordinary General Meeting (the "EGM"), to be held on the 8thMay, 2007. . A circular describing the proposed issue of the Loan Note andconvening the EGM will be sent to shareholders this week. Principal Terms of the Loan Note • The Loan Note attracts interest at 8% per annum, paid half-yearly. • The Loan Note is convertible at the option of the holder at any time prior to the redemption date (being the date five years from the date of issue of the Loan Note) at a price of £0.29 per share, a premium of 28.9% to the closing price at the 10th April. (£0.225 per share). • The number of ordinary shares of 10 pence each to be issued upon conversion of the Loan Note are subject to proportional adjustments to reflect stock dividends, share splits, reverse share splits and other anti-dilutive events. • Should the Company elect to divest any or all of the uranium assets into a new company, the Loan Note shall be convertible at the option of the holder into shares in such company at a price not greater than the price per share of the shares in such company issued to new investors in the first round of a fundraising. • Upon a change of control involving the acquisition of voting control or direction of over 50% or more of the ordinary shares of the Company, the holder has the right to require the Company to redeem the Loan Note, in whole or in part, at a price equal to 101% of the principal amount, plus accrued and unpaid interest thereon. Additionally, shareholders will be aware that the Company raised £750,000 inSeptember 2006 through a convertible loan note agreement with City NaturalResources High Yield Trust Plc and Geiger Counter Limited, who loaned £450,000and £300,000 respectively. Should shareholder approval be obtained in respect ofthe Loan Note, Geiger Counter and City Natural Resources have irrevocablyundertaken to exercise their conversion rights on the existing loan note intoordinary shares of the Company at the agreed price of 12p, this will happen onthe issue of the new loan note and no further interest will be payable from thatpoint on the £750,000. Matthew Idiens, Director of Corporate Development, commented, "We are verypleased to announce this funding which will allow us to continue to acceleratethe development of our uranium portfolio in the US. The uranium market is hereto stay and we believe that the time is now right to explore ways in which wecan extract the maximum value from our uranium assets. We are also delightedthat Geiger Counter, the specialist uranium fund, has likewise recognised thepotential uplift and further cemented their support for VANE." Enquiries: VANE Minerals Plc Ambrian Partners LimitedMatthew Idiens Richard Brown+44 (0) 20 7667 6322 +44 (0) 20 7776 6417 Parkgreen Communications Daniel Stewart & CoCathy Malins / Annabel Leather Katie Shelton+44 (0) 20 7851 7480 +44 (0)20 7776 6550 About VANE Minerals: Since December 2004, VANE Minerals has built a substantial uranium portfolio ofproperties in the US, initially targeting the Northern Arizona Breccia PipeDistrict which holds the highest grade deposits in the US. The Company is using the silver/gold production at the Diablito mine in Mexicoto help fund exploration work across its attractive portfolio of uranium as wellas base and precious metal prospects. VANE was founded by the former international exploration team ofFreeport-McMoRan Copper & Gold Inc., one of the world's largest producers ofcopper and gold. The Company has assembled a highly qualified and experiencedmanagement team with a proven track record in exploration and development, whohave spent their entire careers searching for and defining large scale mineraldeposits. For further information, please review: www.vaneminerals.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Dec 20191:00 pmRNSTotal Voting Rights
3rd Dec 201912:27 pmRNSIssue of Equity and change to TVR
29th Nov 20195:00 pmRNSTotal Voting Rights
22nd Nov 20194:52 pmRNSHolding(s) in Company
21st Nov 201912:43 pmRNSResult of General Meeting and change to TVR
14th Nov 20192:10 pmRNSHolding(s) in Company
8th Nov 20194:12 pmRNSHolding(s) in Company
4th Nov 20192:16 pmRNSDirector/PDMR shareholding
4th Nov 20197:05 amRNSIssue of equity and notice of general meeting
4th Nov 20197:00 amRNSProposed Acquisition-McCoy Interest & Fundraising
14th Oct 20197:00 amRNSRestructuring of the Paradox project
30th Sep 20197:00 amRNSHalf-year Report
3rd Sep 20197:00 amRNSDirectorate Changes and Board Restructuring
2nd Sep 201910:59 amRNSHolding(s) in Company
30th Aug 20195:00 pmRNSTotal Voting Rights
22nd Aug 20197:00 amRNSIssue of equity and change to total voting rights
30th Jul 201912:46 pmRNSResult of AGM and update on Board composition
10th Jul 20193:01 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSBoard appointment and update
28th Jun 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSNotice of Annual Results
3rd Jun 20197:00 amRNSTotal Voting Rights
24th May 20197:00 amRNSSubscription completion, board appointment & TVR
20th May 20197:00 amRNSIssue of equity and Board Changes
30th Apr 20197:00 amRNSUpdated Corporate Presentation
23rd Apr 20197:00 amRNSDirectorate Change
12th Apr 20193:40 pmRNSHolding(s) in Company
12th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSIssue of equity and Board Changes
28th Mar 20197:00 amRNSUpdate & Proposed Board Changes
26th Mar 20199:41 amRNSHolding in Company - Correction
12th Mar 20194:17 pmRNSHolding(s) in Company
5th Mar 20196:09 pmRNSHolding(s) in Company
5th Mar 20199:12 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSAcquisition of additional acreage in Paradox Basin
7th Jan 20197:00 amRNSSchlumberger Study Results
6th Dec 20187:00 amRNSOperations Update
27th Nov 20187:00 amRNSDatabase Agreement & North Wash Vanadium update
1st Nov 20187:00 amRNSBLM Approval for Permit to Drill GV 22-1 well
3rd Oct 20187:00 amRNSHolding(s) in Company
25th Sep 20187:00 amRNSHalf-year Report
18th Jul 20181:46 pmRNSHolding(s) in Company
18th Jul 20181:44 pmRNSHolding(s) in Company
3rd Jul 20181:47 pmRNSCantor Fitzgerald initiates research coverage
28th Jun 201811:28 amRNSResult of AGM
28th Jun 20187:00 amRNSInterviews with CEO Matthew Idiens
22nd Jun 20187:00 amRNSCPR - Maiden Contingent Resource and NPV Estimate
19th Jun 20187:00 amRNSAppointment of Financial Adviser and Joint Broker
14th Jun 20187:00 amRNSHolding(s) in Company
6th Jun 20187:00 amRNSFinal Results & notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.